Rockwell Medical Stock Keeps Nasdaq Listing After Compliance Notice
Rockwell Medical Inc RMTI
$7.19
▲ +1.27%
(+$0.09)
🗓️ Earnings Next Week
Open
$7.24
Prev Close
$7.10
Day Range
$7.07 – $7.26
52W Range
$4.89 – $21.00
Market Cap
$28.38M
Beta
1.62
EPS (TTM)
$-0.15
📋 Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 1998-01-27 |
| Shares Out. | 3,950,000 |
| Website | rockwellmed.com/ ↗ |
| Phone | 13026587581 |
| Employees | 157 |
| Revenue | $17.3M |
| Gross Profit | $2.9M |
| Net Income | -$1.6M |
| Free Cash Flow | $1.8M |
| Total Assets | $57.4M |
| Total Liabilities | $21.6M |
| Equity | $35.9M |
About Rockwell Medical Inc
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, acid, and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate, among others. The company delivers the majority of its hemodialysis concentrates products and mixers to dialysis clinics throughout the United States and internationally, utilizing its own delivery trucks and third-party carriers.
Rockwell Medical Inc is a publicly traded company under the ticker symbol RMTI on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
8 analysts (2026-07-01)